BL
GILD icon

Balentine LLC’s Gilead Sciences GILD Stock Holding History

Balentine LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,867
Closed -$503K – 332
2024
Q1 		$503K Sell
6,867
-938
-12% -$72.1K 0.02% 292
2023
Q4 		$632K Sell
7,805
-2,620
-25% -$204K 0.02% 241
2023
Q3 		$781K Sell
10,425
-71
-0.7% -$5.46K 0.03% 194
2023
Q2 		$809K Sell
10,496
-5,784
-36% -$461K 0.03% 193
2023
Q1 		$1.35M Sell
16,280
-863
-5% -$71.5K 0.05% 122
2022
Q4 		$1.47M Buy
17,143
+1,781
+12% +$141K 0.05% 134
2022
Q3 		$948K Sell
15,362
-5,992
-28% -$378K 0.04% 168
2022
Q2 		$1.32M Buy
21,354
+11,584
+119% +$717K 0.05% 158
2022
Q1 		$581K Sell
9,770
-1,018
-9% -$65.1K 0.02% 267
2021
Q4 		$783K Buy
10,788
+4,694
+77% +$323K 0.03% 110
2021
Q3 		$426K Buy
+6,094
New +$428K 0.02% 141
2020
Q3 		– Sell
-2,638
Closed -$203K – 440
2020
Q2 		$203K Buy
2,638
+478
+22% +$36.6K 0.01% 101
2020
Q1 		$161K Buy
2,160
+829
+62% +$57.3K 0.01% 78
2019
Q4 		$86K Buy
1,331
+899
+208% +$58.5K ﹤0.01% 133
2019
Q3 		$27K Buy
432
+29
+7% +$1.9K ﹤0.01% 200
2019
Q2 		$27K Buy
+403
New +$26.5K ﹤0.01% 178
2018
Q1 		– Sell
-154
Closed -$11K – 240
2017
Q4 		$11K Sell
154
-1,272
-89% -$96.6K ﹤0.01% 455
2017
Q3 		$116K Hold
1,426
– – 0.01% 168
2017
Q2 		$101K Hold
1,426
– – 0.01% 172
2017
Q1 		$97K Buy
1,426
+1,270
+814% +$89.3K 0.01% 168
2016
Q4 		$11K Sell
156
-5
-3% -$372 ﹤0.01% 396
2016
Q3 		$13K Hold
161
– – ﹤0.01% 318
2016
Q2 		$13K Buy
+161
New +$14.3K ﹤0.01% 303
2015
Q4 		– Sell
-3,942
Closed -$387K – 432
2015
Q3 		$387K Buy
3,942
+3,579
+986% +$397K 0.07% 38
2015
Q2 		$43K Sell
363
-103
-22% -$11.3K 0.01% 160
2015
Q1 		$46K Buy
+466
New +$47.3K 0.01% 152

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balentine LLC's GILD Position: Q2 2024 in Review

Balentine LLC sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 6,867 shares — an estimated $503K sold.

Balentine LLC first reported a position in GILD in Q1 2015 and held it in 26 quarters. The position peaked at $1.47M in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Balentine LLC reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 6,867 Gilead Sciences shares in Q2 2024, an estimated $503K.
  • Balentine LLC first reported a position in Gilead Sciences in Q1 2015 and held it in 26 quarters.
  • Balentine LLC's Gilead Sciences position peaked at $1.47M in Q4 2022.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.